iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Torrent Pharma’s Gujarat facility gets 1 observation from USFDA

20 Mar 2023 , 03:38 PM

Torrent Pharmaceuticals announced that its Oral-Oncology manufacturing facility located in Bileshwarpura, Gujarat, has undergone a Pre-Approval Inspection (PAI) by the US Food and Drug Administration (FDA) and has been completed. 

After inspecting the facility, the USFDA has issued a Form 483 containing only one observation.

From March 13 to March 17, the US Food and Drug Administration (USFDA) carried out a pre-approval inspection of Torrent Pharma's plant situated in Bileshwarpura.

In its bourse filing, Torrent Pharmaceuticals reported “the USFDA conducted a Pre-Approval Inspection (PAI) at its Oral-Oncology manufacturing facility situated in Bileshwarpura, Gujarat from March 13 to March 17. 

The company further stated, 'at the end of the inspection, we were issued a 'Form 483' with one procedural observation.'

According to the filing, the company has stated that it will respond to the USFDA within the prescribed timeframe and will work in close collaboration with the agency to address the observation at the earliest possible time.

For feedback and suggestions, write to us at editorial@iifl.com

explored-media

Related Tags

  • Torrent Pharma
  • Torrent Pharma News
  • Torrent Pharmaceuticals
  • USFDA News
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.